A study of patients with metastatic melanoma showed that exosomes released from melanoma cells carry PD-L1 on their surface, and that the increase in levels of circulating exosomal PD-L1 correlates with tumor response to anti-PD-1 therapy [87]. Here, CD274 is linked to melanoma.